New FDA-Approved Treatments for MS
Dr. Rae Bacharach discusses two new, disease-modifying therapies for use in multiple sclerosis.

Dr. Rae Bacharach discusses two new, disease-modifying therapies for use in multiple sclerosis.
Dr. Gregory Day discusses the recognition of transient epileptic amnesia. To learn more, read Dr. Day’s article, “Reversible Dementias,” in the February 2019 Dementia issue of Continuum.
Dr. Brigid Waldron-Perrine talks about the Montreal Cognitive Assessment as a screening tool.
Dr. Mathias Jucker discusses the use of neurofilament light as a potential biomarker for Alzheimer's Disease.
Dr. Jonathan Graff-Radford, guest editor of the February 2019 Dementia issue of Continuum , discusses behavioral-variant frontotemporal dementia. To learn more, read the article “Behavioral Variant Frontotemporal Dementia” by Dr. William W. Seeley in that issue.
Dr. Mathias Buron discusses the takeaways from his paper the comparative effectiveness of teriflunomide and dimethyl fumarate.
Dr. Joanna Hellmuth discusses the findings of her paper on the rise of pseudomedicine for dementia and brain health.
Dr. Roy Strowd discusses a recent Clinical Reasoning case about a 65-year-old female with subacute hemiballism.
Dr. Jonathan Graff-Radford, guest editor of the February 2019 Dementia issue of Continuum , discusses hippocampal sclerosis of aging. To learn more, read the article “Hippocampal Sclerosis, Argyrophilic Grain Disease, and Primary Age-related Tauopathy” by Drs. Gregory A. Jicha and Peter T. Nelson in that issue.
Dr. Caterina Lapucci talks about her paper addressing how much periventricular lesions assist in distinguishing migraine with aura from CIS.
Sarah Karlin-Smith and Sarah Owermohle from Politico talk about drug pricing and legislation to affect drug pricing.
Dr. Roy Strowd showcases a Clinical Reasoning case on a pregnant woman presenting with chin numbness.
Dr. Gregory Day offers a practical approach to recognizing patients with reversible dementia. To learn more, read Dr. Day’s article, “Reversible Dementias,” in the February 2019 Dementia issue of Continuum .
Dr. Stephan Schuele discusses the main takeaways from his paper on automated seizure detection accuracy for ambulatory EEG recordings.
Dr. Kevin Barrett discusses the SHINE stroke trial, which was designed to determine the optimal treatment of hyperglycemia in acute stroke.
Dr. Joe Sirven previews the upcoming 2019 AAN Annual Meeting in Philadelphia.
Dr. John Millichap discusses a clinical pediatric R&F case of a 15-year-old boy with bilateral wrist pain in the setting of weight loss.
Dr. Jonathan Graff-Radford, guest editor of the February 2019 Dementia issue of Continuum , discusses an important imaging finding when evaluating patients for ventriculomegaly called disproportionately large subarachnoid space hydrocephalus (DESH). To learn more, read the article “Normal Pressure Hydrocephalus” by Drs. Neill R. Graff-Radford and David T. Jones in that issue.
Dr. Stephen Klasko talks about the future of hospital systems and healthcare, based on a panel at the World Economic Forum in Davos.
Dr. Anneleen Berende discusses the effect of prolonged antibiotic treatment on cognitive performance in patients with Lyme borreliosis.
Dr. Anneleen Berende discusses whether or not prolonged antibiotics are beneficial for neurocognition in Lyme borreliosis.
Dr. Stephen Klasko talks about the future of hospital systems and healthcare, based on a panel at the World Economic Forum.
Dr. Joe Sirven previews the 2019 AAN Annual Meeting.
Dr. John Millichap discusses a recent pediatric R&F case on West syndrome, pontocerebellar hypoplasia, and Hypomyelination in a 6-month-old boy.
Dr. Jonathan Graff-Radford, guest editor of the February 2019 Dementia issue of Continuum , discusses updates to criteria for dementia with Lewy bodies. To learn more, read the article “Lewy Body Dementias” by Dr. Melissa J. Armstrong in that issue.
Dr. Jason Crowell talks with Dr. Rob de Bie about when to start Levodopa in Parkinson's Disease.
Dr. Jason Crowell discusses delayed start of levodopa for Parkinson's with Dr. Rob de Bie. Dr. de Bie's article can be found here: https://www.nejm.org/doi/full/10.1056/NEJMoa1809983 .
Dr. Stacey Clardy reminds you to join us at the 2019 American Academy of Neurology Annual Meeting.
Dr. Stacey Clardy discusses the DEFUSE 3 study with Dr. Adam de Havenon.
Dr. Stacey Clardy talks with Dr. Patrick Waters about MOG-IgG cell based assays.